Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
Authors:
Open Access
- 25 August 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
Abstract
Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy. Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical routines. Next-generation sequencing (NGS) technologies are emerging as a more comprehensive and time- and cost-effective approach in PGx. This review presents the main considerations for applying NGS in guiding drug treatment in clinical practice. It discusses both the advantages and the challenges of implementing NGS-based tests in PGx. Moreover, the limitations of each NGS platform are revealed, and the solutions for setting up and management of these technologies in clinical practice are addressed.Keywords
Funding Information
- Framework Programme
This publication has 99 references indexed in Scilit:
- Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testingGenetics in Medicine, 2013
- Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical PracticeISRN Pharmacology, 2013
- Multimodality Imaging of Left Ventricular Apical Pouch With Midventricular Cavity ObliterationJACC, 2012
- Copy number variants in pharmacogenetic genesTrends in Molecular Medicine, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- VKORC1 Pharmacogenomics SummaryPharmacogenetics and Genomics, 2010
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactionsNucleic Acids Research, 2009
- Addressing the Challenges of the Clinical Application of Pharmacogenetic TestingClinical Pharmacology & Therapeutics, 2009
- Development of a PCR-Based Strategy forCYP2D6Genotyping Including Gene Multiplication of Worldwide Potential UseBioTechniques, 2005
- The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's SyndromeNew England Journal of Medicine, 1995